Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat for HIV Latency Reversal
NCT01365065Phase 2Unknown
- Start
- May 2011
- Primary completion
- Dec 2011
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in human immunodeficiency virus infection (HIV). Status: unknown.
02
Drugs
vorinostat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01365065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365065.